GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Long-Term Debt

OKUR (OnKure Therapeutics) Long-Term Debt : $0.00 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Long-Term Debt?

OnKure Therapeutics's Long-Term Debt for the quarter that ended in Dec. 2024 was $0.00 Mil.

OnKure Therapeutics's quarterly Long-Term Debt declined from Jun. 2024 ($5.86 Mil) to Sep. 2024 ($0.00 Mil) but then stayed the same from Sep. 2024 ($0.00 Mil) to Dec. 2024 ($0.00 Mil).

OnKure Therapeutics Long-Term Debt Historical Data

The historical data trend for OnKure Therapeutics's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OnKure Therapeutics Long-Term Debt Chart

OnKure Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Long-Term Debt
- - -

OnKure Therapeutics Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only - - 5.86 - -

OnKure Therapeutics  (NAS:OKUR) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

OnKure Therapeutics Long-Term Debt Related Terms

Thank you for viewing the detailed overview of OnKure Therapeutics's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

OnKure Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Long-Term Debt
Comparable Companies
APLT QNCX GUTS INZY IMRX CNTX ANRO CYCC CUE STRO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
Website
https://www.onkuretherapeutics.com
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.